RareiTi, a technology enabled, data-driven Managed Access company to the pharmaceutical industry, has named Dr Olivia Kessel as its new chief medical officer, it was reported on Tuesday.
The company said that Dr Kessel has more than two decades of experience concentrated on patient empowerment and creating patient-centric solutions. She launched AbbVie Care in the UK and is the founder of Evolve Care. She has been named honorary professor for Patient Centric Design at the De Montfort University in Leicester, United Kingdom. She is former chairperson at Head Medical and served Ingeus as medical director.
RareiTi co-founders Natalie Douglas and Wendy White said, 'As a physician and entrepreneur with significant pharma industry experience, Olivia's credentials provide the perfect fit to meet the needs of our clients and their patient communities.'
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer